Green Dot (NYSE:GDOT) was downgraded today by Morgan Stanley (NYSE:MS) to equal weight from overweight with a price target of $25 due to competitive and regulatory pressures currently facing the company.
Shares are lower by about four tenths of a percent.
Human Genome (HGSI) was downgraded today by BMO Capital (NYSE:BMO) to market perform with a price target of $13, as GlaxoSmithKline may drop its buyout offer for the company.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.